The Food and Drug Administration on Wednesday approved GlaxoSmithKline's vaccine against the respiratory syncytial virus, making it the first authorized RSV shot in the U.S.
FDA Approves United States' First-ever RSV Vaccine
Comment
Show comments
Hide Comments
